Perioperative outcomes of syndromic paraganglioma and pheochromocytoma resection in patients with von Hippel-Lindau disease, multiple endocrine neoplasia type 2, or neurofibromatosis type 1
- PMID: 28919049
- DOI: 10.1016/j.surg.2017.08.002
Perioperative outcomes of syndromic paraganglioma and pheochromocytoma resection in patients with von Hippel-Lindau disease, multiple endocrine neoplasia type 2, or neurofibromatosis type 1
Abstract
Background: Pheochromocytoma and/or paraganglioma associated with neurofibromatosis type 1, multiple endocrine neoplasia type 2A, and von Hippel-Lindau disease have different catecholamine biochemical phenotypes. We examined perioperative outcomes of pheochromocytoma/paraganglioma resection in 3 syndromic forms.
Methods: Retrospective review of patients undergoing resection of syndromic pheochromocytoma/paraganglioma from 2000 through 2016.
Results: Eighty-one patients underwent pheochromocytoma/paraganglioma resection (multiple endocrine neoplasia type 2A, n = 36; neurofibromatosis type 1, n = 26; von Hippel-Lindau disease, n = 19). Tumor size differed across groups; patients with neurofibromatosis type 1 and von Hippel-Lindau disease had the largest tumors (P = .017). Larger tumor volumes correlated with higher urine 24-hour total metanephrine (r = 0.94, P < .001; r = 0.67, P = .033; and r = 0.89, P < .001 for multiple endocrine neoplasia type 2A, von Hippel-Lindau disease, and neurofibromatosis type 1, respectively). High adrenergic secretion (24-hour urine metanepinephrine) was found in neurofibromatosis type 1 (median, 861 μg/24 h), similar to that found in multiple endocrine neoplasia type 2A (median, 809 μg/24 h). The highest noradrenergic secretion (24-hour urine normetanephrine) occurred with von Hippel-Lindau disease (median, 4,598 μg/24 h), followed by neurofibromatosis type 1 and multiple endocrine neoplasia type 2A (median, 1,607 and 923 μg/24 h, respectively). The highest graded complications occurred among patients with neurofibromatosis type 1 (P = .036). However, when comparing postoperative outcomes across 3 groups in those who had laparoscopic resection, there was no significant difference (P = .955).
Conclusion: Patients with neurofibromatosis type 1 had the most volatile intraoperative hemodynamic course and more severe postoperative complications. These complications are related to large tumors associated with abundant catecholamine secretion and the fact that a high proportion underwent open resection. Among only patients who underwent laparoscopic procedures, there were no differences in postoperative outcomes across syndromic groups.
Copyright © 2017 Elsevier Inc. All rights reserved.
Similar articles
-
Surgical management of hereditary pheochromocytoma.J Am Coll Surg. 2004 Apr;198(4):525-34; discussion 534-5. doi: 10.1016/j.jamcollsurg.2003.12.001. J Am Coll Surg. 2004. PMID: 15051000
-
Plasma normetanephrine and metanephrine for detecting pheochromocytoma in von Hippel-Lindau disease and multiple endocrine neoplasia type 2.N Engl J Med. 1999 Jun 17;340(24):1872-9. doi: 10.1056/NEJM199906173402404. N Engl J Med. 1999. PMID: 10369850
-
Laparoscopic resection of periadrenal paraganglioma in a patient with multiple endocrine neoplasia type 2A.Surg Laparosc Endosc Percutan Tech. 2011 Feb;21(1):e31-3. doi: 10.1097/SLE.0b013e3182074c72. Surg Laparosc Endosc Percutan Tech. 2011. PMID: 21304370
-
Update on Pheochromocytoma and Paraganglioma from the SSO Endocrine and Head and Neck Disease Site Working Group, Part 2 of 2: Perioperative Management and Outcomes of Pheochromocytoma and Paraganglioma.Ann Surg Oncol. 2020 May;27(5):1338-1347. doi: 10.1245/s10434-020-08221-2. Epub 2020 Feb 28. Ann Surg Oncol. 2020. PMID: 32112213 Free PMC article. Review.
-
Phaeochromocytomas and sympathetic paragangliomas.Br J Surg. 2009 Dec;96(12):1381-92. doi: 10.1002/bjs.6821. Br J Surg. 2009. PMID: 19918850 Review.
Cited by
-
Phase II Clinical Trial of Pembrolizumab in Patients with Progressive Metastatic Pheochromocytomas and Paragangliomas.Cancers (Basel). 2020 Aug 16;12(8):2307. doi: 10.3390/cancers12082307. Cancers (Basel). 2020. PMID: 32824391 Free PMC article.
-
Maternal and fetal outcomes in phaeochromocytoma and pregnancy: a multicentre retrospective cohort study and systematic review of literature.Lancet Diabetes Endocrinol. 2021 Jan;9(1):13-21. doi: 10.1016/S2213-8587(20)30363-6. Epub 2020 Nov 26. Lancet Diabetes Endocrinol. 2021. PMID: 33248478 Free PMC article.
-
Glycemic Disturbances in Pheochromocytoma and Paraganglioma.Cureus. 2019 Apr 27;11(4):e4551. doi: 10.7759/cureus.4551. Cureus. 2019. PMID: 31275775 Free PMC article. Review.
-
Clinical Presentation and Outcomes of Phaeochromocytomas/Paragangliomas in Neurofibromatosis Type 1.Eur Endocrinol. 2019 Aug;15(2):95-100. doi: 10.17925/EE.2019.15.2.95. Epub 2019 Aug 16. Eur Endocrinol. 2019. PMID: 31616500 Free PMC article.
-
Changing pattern of pheochromocytoma and paraganglioma in a stable UK population.Acta Endocrinol (Buchar). 2020 Jan-Mar;16(1):78-85. doi: 10.4183/aeb.2020.78. Acta Endocrinol (Buchar). 2020. PMID: 32685043 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials